The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organization

@article{Laffan2004TheDO,
  title={The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organization},
  author={Michael A Laffan and S. A. Brown and Peter W. Collins and Anthony M. Cumming and Frank G. H. Hill and David M Keeling and Ian R. Peake and K. John Pasi},
  journal={Haemophilia},
  year={2004},
  volume={10}
}
Summary.  von Willebrand disease (VWD) is the commonest inherited bleeding disorder. However, despite an increasing understanding of the pathophysiology of VWD, the diagnosis of VWD is frequently difficult because of uncertainty regarding the relationship between laboratory assays and function in vivo. The objective of this guideline is to provide contemporary advice on a rational approach to the diagnosis of VWD. This is the second edition of this UK Haemophilia Centre Doctors’ Organisation… Expand
Evaluation of Diagnostic Criteria for von Willebrand Disease in Sudan
TLDR
The clinical diagnosis of Von Willebrand disease is often difficult because of a considerable intra -individual phenotypic variation and limited laboratory data, bleeding and family history. Expand
Advances in the diagnosis and management of von Willebrand disease
TLDR
In this review, the present knowledge regarding the diagnosis and the management of VWD is briefly analyzed. Expand
The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organisation Haemophilia Genetics Laboratory Network
TLDR
This guideline aims to provide a framework for best laboratory practice for the genetic diagnosis of VWD, based upon current knowledge and understanding. Expand
Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population
TLDR
The objective of this study was to apply ISTH and HSC criteria to a large pediatric population previously diagnosed with type 1 VWD, and hypothesized that a substantial number of patients would not meet these diagnostic criteria. Expand
von Willebrand Disease: Diagnosis and Treatment
TLDR
The International Society on Thrombosis and Haemostasis/Scientific and Standardization Committee (ISTH/SSC) reviewed the classification and published update information on the diagnosis and treatment of VWD in 2006 based on the most recent pathophysiology data for VWF. Expand
Type 1 von Willebrand disease: application of emerging data to clinical practice
TLDR
In patients with VWF levels close to the lower end of the normal range, candidate mutations are found less often, ABO blood group is a more important factor and the disease has variable heritability within families. Expand
Application of UKHCDO 2004 guidelines in type 1 von Willebrand Disease ‐ a single centre paediatric experience of the implications of altered or removed diagnosis
TLDR
This study is the first to assess the impact of the 2004 UKHCDO Guidelines on the diagnosis of VWD and provides evidence that the prevalence of type 1 VWD may actually be closer to that of haemophilia instead of the previously reported 1–3% of the general population. Expand
Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination
TLDR
Type 2B patients can be discriminated from other qualitative VWD variants by using ristocetin‐induced platelet agglutination (RIPA) test, but the major limitation of RIPA is the requirement of fresh blood sample. Expand
A practical approach to genetic testing for von Willebrand disease.
TLDR
This article provides a practical approach to utilization of genetic testing in von Willebrand disease and shows how judicious use will be increasingly important for appropriate genetic-counseling of patients with vWD and their family members. Expand
Diagnostic approach to von Willebrand disease.
TLDR
The ability to accurately and appropriately diagnose individuals withvon Willebrand disease continues to be an important and much-needed tool in the treatment of VWD. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 97 REFERENCES
Impact, diagnosis and treatment of von Willebrand disease.
TLDR
There are at least 580,000 persons with symptomatic VWD worldwide who could benefit from appropriate diagnosis followed by replacement or pharmacological therapy, and 80% of these persons live in the developing world. Expand
Diagnosis of von Willebrand disease
TLDR
The diagnosis of types and subtypes of vWD is based on measurements of plasma and platelet vWF, the ability of vWF to interact with its platelet receptor and the analysis of the multimeric composition ofvWF. Expand
Acquired von Willebrand syndrome: data from an international registry.
TLDR
It appears that AvWS is especially frequent in lympho- or myeloproliferative and cardiovascular diseases and should be suspected and searched with the appropriate laboratory tests especially when excessive bleeding occurs in patients with these disorders. Expand
Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA‐100® and vWF:CBA as combined diagnostic strategies
TLDR
The coevaluated test processes for diagnosing von Willebrand disease (vWD) and monitoring deamino‐δ‐D‐arginine vasopressin (DDAVP) therapy concluded that the PFA‐100® is highly sensitive to the presence of vWD, and may thus provide a valuable screening test for vWD. Expand
Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
  • D. Ginsburg, B. Konkle, +4 authors A. Yang
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1989
TLDR
A silent vWF allele was identified, resulting from a cis defect in vWF mRNA transcription or processing, and two different but adjacent missense mutations were identified, the locations of which may identify an important vWF functional domain. Expand
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
TLDR
Using the ISTH consensus guidelines for type 1 VWD definition, significantly fewer patients were diagnosed with definite type 1 disease as compared to the "in house" Hospital for Sick Children (HSC) criteria (4 vs. 31). Expand
Acquired von Willebrand disease.
TLDR
Therapeutic options include desmopressin and certain factor VIII concentrates that also contain vWF, and intravenous immunoglobulins have also shown some efficacy in the management of AvWD, especially cases associated with monoclonal gammopathies. Expand
von Willebrand factor and von Willebrand disease.
TLDR
This review summarizes the current knowledge on vWF and vWD, and identifies the regions of the molecule that interact with factor VIII, heparin, the glycoprotein lb of platelets, and collagen. Expand
Type 1 von Willebrand disease — a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history
TLDR
The results suggest that the use of ABO adjusted ranges for VWF levels might not be essential for diagnosis, because bleeding symptoms may depend on the VWF level regardless of the ABO type. Expand
von Willebrand factor is an acute phase reactant in man.
Plasma von Willebrand factor antigen (vWfAg) concentrations in 19 patients with acute infectious illnesses of bacterial, viral or parasitic origin were significantly elevated with a mean greater thanExpand
...
1
2
3
4
5
...